Trial Profile
A prospective, multicentre, cohort study will investigate the efficacy and safety of peginterferon alpha - 2a or peginterferon alpha - 2b plus ribavirin therapy in patients with chronic hepatitis C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Peginterferon alfa-2b (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms PROBE
- 15 Dec 2015 New trial record